 | (2S,3R,4S,5R)-2-Methylpiperidine-3,4,5-triol | IC50 | 140.0 [1], 410.0 [2] |
| (2S,3R,4S,5R)-2-Methylpiperidine-3,4,5-triol | Ki | 6.2 [1] |
 | (2S)-2-Amino-3-hydroxy-N-[[3,4,5-trihydroxy-2-(hydroxymethyl)-6-methylpiperidin-2-yl]methyl]propanamide | IC50 | 20.0 [1], 40.0 [2], 56.0 [3] |
| (2S)-2-Amino-3-hydroxy-N-[[3,4,5-trihydroxy-2-(hydroxymethyl)-6-methylpiperidin-2-yl]methyl]propanamide | Ki | 19.0 [1], 30.0 [2], 47.0 [3] |
 | (3,4,5-Trihydroxy-2-hydroxymethyl-6-methyl-piperidin-1-yl)-acetaldehyde | IC50 | 4.0 [1], 11.0 [2] |
| (3,4,5-Trihydroxy-2-hydroxymethyl-6-methyl-piperidin-1-yl)-acetaldehyde | Ki | 1.5 [1], 8.0 [2], 11.0 [3] |
 | Ethyl 5-[(2R,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-2-methyl-3-furoate | IC50 | 200000.0 [1], 300000.0 [2] |
| Ethyl 5-[(2R,3S,4R)-3,4-dihydroxypyrrolidin-2-yl]-2-methyl-3-furoate | Ki | 9000.0 [1], 15000.0 [2] |
 | 5-[(2R,3S,4R)-3,4-Dihydroxypyrrolidin-2-yl]-N,N-diethyl-2-methyl-3-furamide | IC50 | 85000.0 [1], 220000.0 [2] |
| 5-[(2R,3S,4R)-3,4-Dihydroxypyrrolidin-2-yl]-N,N-diethyl-2-methyl-3-furamide | Ki | 9100.0 [1], 20100.0 [2] |
 | 5-[(2R,3S,4R)-3,4-Dihydroxypyrrolidin-2-yl]-N-isopropyl-2-methyl-3-furamide | IC50 | 40000.0 [1], 80000.0 [2] |
| 5-[(2R,3S,4R)-3,4-Dihydroxypyrrolidin-2-yl]-N-isopropyl-2-methyl-3-furamide | Ki | 3000.0 [1], 5300.0 [2] |
 | Ethyl 5-(3,4-dihydroxypyrrolidin-2-yl)-2-methylfuran-3-carboxylate | IC50 | 200000.0 [1], 300000.0 [2] |
| Ethyl 5-(3,4-dihydroxypyrrolidin-2-yl)-2-methylfuran-3-carboxylate | Ki | 9000.0 [1], 15000.0 [2] |
 | 5-(3,4-Dihydroxypyrrolidin-2-yl)-N,N-diethyl-2-methylfuran-3-carboxamide | IC50 | 110000.0 [1], 220000.0 [2] |
| 5-(3,4-Dihydroxypyrrolidin-2-yl)-N,N-diethyl-2-methylfuran-3-carboxamide | Ki | 9100.0 [1], 20100.0 [2] |
 | 5-(3,4-Dihydroxypyrrolidin-2-yl)-2-methyl-N-propan-2-ylfuran-3-carboxamide | IC50 | 40000.0 [1], 80000.0 [2] |
| 5-(3,4-Dihydroxypyrrolidin-2-yl)-2-methyl-N-propan-2-ylfuran-3-carboxamide | Ki | 3000.0 [1], 5300.0 [2] |
 | 5-(3,4-Dihydroxypyrrolidin-2-yl)-N-ethyl-2-methylfuran-3-carboxamide | IC50 | 40000.0 [1], 80000.0 [2] |
| 5-(3,4-Dihydroxypyrrolidin-2-yl)-N-ethyl-2-methylfuran-3-carboxamide | Ki | 3200.0 [1], 4800.0 [2] |
 | Propan-2-yl 5-(3,4-dihydroxypyrrolidin-2-yl)-2-methylfuran-3-carboxylate | IC50 | 50000.0 [1], 160000.0 [2] |
| Propan-2-yl 5-(3,4-dihydroxypyrrolidin-2-yl)-2-methylfuran-3-carboxylate | Ki | 4900.0 [1], 8600.0 [2] |
 | Methyl 5-(3,4-dihydroxypyrrolidin-2-yl)-2-methylfuran-3-carboxylate | IC50 | 100000.0 [1], 150000.0 [2] |
| Methyl 5-(3,4-dihydroxypyrrolidin-2-yl)-2-methylfuran-3-carboxylate | Ki | 6500.0 [1], 13800.0 [2] |
 | 1-Deoxymannojirimycin | IC50 | 221000.0 [1] |
| 1-Deoxymannojirimycin | Ki | 4700.0 [1], 30000.0 [2] |
 | 4-Methyl-6-octylamino-cyclohexane-1,2,3-triol | IC50 | 110.0 [1], 5500.0 [2] |
| 4-Methyl-6-octylamino-cyclohexane-1,2,3-triol | Ki | 16.0 [1] |
 | (1R,2R,3R,4S,6R)-4-Amino-6-methylcyclohexane-1,2,3-triol | IC50 | 25000.0 [1] |
| (1R,2R,3R,4S,6R)-4-Amino-6-methylcyclohexane-1,2,3-triol | Ki | 12.0 [1], 2900.0 [2] |
 | (1R,2R,3R,4R,6R)-4-Amino-6-methylcyclohexane-1,2,3-triol | IC50 | 9300.0 [1] |
| (1R,2R,3R,4R,6R)-4-Amino-6-methylcyclohexane-1,2,3-triol | Ki | 12.0 [1], 1000.0 [2] |
 | (3R,4S,5R)-2-(Hydroxymethyl)-6-methylpiperidine-3,4,5-triol | Ki | 5.8 [1] |
 | 2-Aminomethylsulfanyl-6-methyl-tetrahydro-pyran-3,4,5-triol | Ki | 5900.0 [1], 6100.0 [2], 6800.0 [3] |
 | N-(3,4,5-Trihydroxy-6-methyl-tetrahydro-pyran-2-ylsulfanylmethyl)-acetamide | Ki | 3900.0 [1], 4600.0 [2], 5600.0 [3] |
 | 3,4,5-Trihydroxy-2-hydroxymethyl-6-methyl-piperidine-2-carbonitrile | IC50 | 75.0 [1], 110.0 [2], 122.0 [3] |
 | 2-Aminomethyl-2-hydroxymethyl-6-methyl-piperidine-3,4,5-triol | IC50 | 80.0 [1], 160.0 [2], 206.0 [3] |
 | Benzyl N-[2-oxo-2-[[3,4,5-trihydroxy-2-(hydroxymethyl)-6-methylpiperidin-2-yl]methylamino]ethyl]carbamate | IC50 | 40.0 [1], 190.0 [2], 200.0 [3] |
 | 2-Amino-N-[[3,4,5-trihydroxy-2-(hydroxymethyl)-6-methylpiperidin-2-yl]methyl]acetamide | IC50 | 50.0 [1], 116.0 [2], 170.0 [3] |
 | L-Fucose | Ki | 300000.0 [1] |
 | 1-Deoxynojirimycin | IC50 | 26000.0 [1] |
| 1-Deoxynojirimycin | Ki | 100000000.0 [1] |
 | (2S,3S,4R,5S)-2-(Hydroxymethyl)-5-methylpyrrolidine-3,4-diol | Ki | 1400.0 [1], 4000.0 [2] |
 | 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2S,3R,4S,5R)- | IC50 | 3500.0 [1] |
 | (4R)-2-[(3R)-4,5-Dihydroxy-6-(hydroxymethyl)-2-prop-2-enoxyoxan-3-yl]oxy-6-methylthiane-3,4,5-triol | Ki | 210.0 [1], 30000.0 [2] |
 | (4S,5R)-2-Methyl-piperidine-3,4,5-triol | Ki | 5.0 [1], 6.0 [2] |
 | (1R,2S,3S)-4-Benzylamino-6-methyl-cyclohexane-1,2,3-triol | IC50 | 1000.0 [1] |
| (1R,2S,3S)-4-Benzylamino-6-methyl-cyclohexane-1,2,3-triol | Ki | 69.0 [1] |
 | (1R,2S,3S)-4-Butylamino-6-methyl-cyclohexane-1,2,3-triol | IC50 | 920.0 [1] |
| (1R,2S,3S)-4-Butylamino-6-methyl-cyclohexane-1,2,3-triol | Ki | 74.0 [1] |
 | (1S,2S,3R)-4-Methyl-6-nonylamino-cyclohexane-1,2,3-triol | IC50 | 240.0 [1] |
| (1S,2S,3R)-4-Methyl-6-nonylamino-cyclohexane-1,2,3-triol | Ki | 110.0 [1] |
 | 4-Methyl-6-phenethylamino-cyclohexane-1,2,3-triol | IC50 | 240.0 [1] |
| 4-Methyl-6-phenethylamino-cyclohexane-1,2,3-triol | Ki | 32.0 [1] |
 | (1R,2S,3S)-4-Heptylamino-6-methyl-cyclohexane-1,2,3-triol | IC50 | 270.0 [1] |
| (1R,2S,3S)-4-Heptylamino-6-methyl-cyclohexane-1,2,3-triol | Ki | 48.0 [1] |
 | (1R,2S,3S)-4-Ethylamino-6-methyl-cyclohexane-1,2,3-triol | IC50 | 21000.0 [1] |
| (1R,2S,3S)-4-Ethylamino-6-methyl-cyclohexane-1,2,3-triol | Ki | 180.0 [1] |
 | 5-Methylpiperidine-3,4-diol | IC50 | 26000.0 [1] |
| 5-Methylpiperidine-3,4-diol | Ki | 8400.0 [1] |
 | 6-Methylthiane-2,3,4,5-tetrol | Ki | 42000.0 [1], 80000.0 [2] |
 | 2,6-Diiminohexane-1,3,4,5-tetrol | Ki | 7000.0 [1], 11000.0 [2] |
 | (2R,3S,4S,5S,6S)-6-Methyl-5-sulfanyloxane-2,3,4-triol | Ki | 42000.0 [1], 84000.0 [2] |
 | 1-(4-Hydroxy-2-methyl-3,4-dihydro-2H-pyran-3-yl)-ethanone | Ki | 90000.0 [1], 26000000.0 [2] |
 | Migalastat | Ki | 34000000.0 [1] |
 | N-Methyl-1-deoxynojirimycin | Ki | 5300000.0 [1] |
 | Fagomine | IC50 | 140000.0 [1] |
 | Piperidine-3,4,5-triol | IC50 | 1000000.0 [1] |
 | 3-Epi-fagomine | IC50 | 1000000.0 [1] |
 | 2,5-Pyrrolidinedimethanol, 3,4-dihydroxy- | Ki | 910000.0 [1] |
 | (3R,4S)-Pyrrolidine-3,4-diol | Ki | 1000000.0 [1] |
 | (2R,3R,4R,5R,6S)-2-(Hydroxymethyl)-6-methylpiperidine-3,4,5-triol | Ki | 80.0 [1] |
 | 1,6-Dideoxynojirimycin | Ki | 1700000.0 [1] |
 | (2R,3R,5R,6R)-2,6-Bis(hydroxymethyl)piperidine-3,4,5-triol | IC50 | 30000.0 [1] |
 | (2R,3R,5R,6S)-2,6-Bis(hydroxymethyl)piperidine-3,4,5-triol | IC50 | 2600.0 [1] |
 | (2R,3S,4R,5R)-2-(Hydroxymethyl)-5-methylpyrrolidine-3,4-diol | Ki | 9000.0 [1] |
 | 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2S,3R,4R,5R)- | IC50 | 150000.0 [1] |
 | 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2S,3S,4S,5S)- | Ki | 90000000.0 [1] |
 | (2R,3S,4R,5S)-2-Methylpiperidine-3,4,5-triol | Ki | 7900000.0 [1] |
 | 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R,3R,4S,5S)- | IC50 | 194000.0 [1] |
 | (R)-Azepane-3,4,5,6-tetraol | Ki | 28000.0 [1] |
 | (3R,4R,6R)-5,5-Difluoro-6-(hydroxymethyl)piperidine-3,4-diol | Ki | 1000000.0 [1] |
 | (3R,4R,6S)-5,5-Difluoro-6-(hydroxymethyl)piperidine-3,4-diol | Ki | 1000000.0 [1] |
 | (3S,4R,6R)-5,5-Difluoro-6-(hydroxymethyl)piperidine-3,4-diol | Ki | 1000000.0 [1] |
 | 2-Benzylimino-5-methyl-3a,4,5,6,7,7a-hexahydro-3H-1,3-benzoxazole-6,7-diol | IC50 | 72000.0 [1] |
 | 2-Butylimino-5-methyl-3a,4,5,6,7,7a-hexahydro-3H-1,3-benzoxazole-6,7-diol | IC50 | 140000.0 [1] |
 | (2S,3R,4R,5R,6R)-2-Ethyl-6-(hydroxymethyl)piperidine-3,4,5-triol | IC50 | 83000.0 [1] |
 | (1S,2R,3R,5S,7S,8R)-3,5-Bis(hydroxymethyl)-2,3,5,6,7,8-hexahydro-1H-pyrrolizine-1,2,7-triol | IC50 | 17000.0 [1] |
 | (S)-5-Methyl-piperidine-3,4-diol | Ki | 8400.0 [1] |
 | (2R,3R)-4-Amino-6-methyl-cyclohexane-1,2,3-triol | Ki | 230.0 [1] |
 | (R)-4-Amino-5-methyl-cyclopentane-1,2,3-triol | Ki | 15000.0 [1] |
 | (R)-4-Benzylamino-5-methyl-cyclopentane-1,2,3-triol | Ki | 680.0 [1] |
 | (R)-2-Methyl-6-(4-nitro-phenylsulfanyl)-tetrahydro-thiopyran-3,4,5-triol | Ki | 3300.0 [1] |
 | (R)-1-Benzyl-azepane-3,4,5,6-tetraol | Ki | 23400.0 [1] |
 | (R)-6-Methyl-tetrahydro-thiopyran-2,3,4,5-tetraol | Ki | 42000.0 [1] |
 | N-((3R,4R)-3,4,5-Trihydroxy-piperidin-2-ylmethyl)-acetamide | Ki | 4000.0 [1] |
 | 2-Methyl-pyrrolidine-3,4-diol | Ki | 2000.0 [1] |
 | (4R,5R)-Piperidine-3,4,5-triol | Ki | 24000.0 [1] |
 | 5-(3,4-Dihydroxypyrrolidin-2-yl)-2-methyl-N-phenylfuran-3-carboxamide | IC50 | 1000000.0 [1] |
 | CID 44319866 | Ki | 160.0 [1] |
Calculator
